Fujiwara T - Search Results

1

Advances in treatment of alveolar soft part sarcoma: an updated review.

Fujiwara T, Kunisada T, Nakata E, Nishida K, Yanai H, Nakamura T, Tanaka K, Ozaki T. Fujiwara T, et al. Jpn J Clin Oncol. 2023 Nov 5;53(11):1009-1018. doi: 10.1093/jjco/hyad102. Jpn J Clin Oncol. 2023. PMID: 37626447 Free PMC article. Review.

2

[Update on microRNAs research in sarcoma: review the literature and proposal of the clinical application].

Fujiwara T, Kawai A, Kosaka N, Ozaki T, Ochiya T. Fujiwara T, et al. Gan To Kagaku Ryoho. 2013 Mar;40(3):305-13. Gan To Kagaku Ryoho. 2013. PMID: 23560331 Japanese. No abstract available.

3

Clinical relevance and therapeutic significance of microRNA-133a expression profiles and functions in malignant osteosarcoma-initiating cells.

Fujiwara T, Katsuda T, Hagiwara K, Kosaka N, Yoshioka Y, Takahashi RU, Takeshita F, Kubota D, Kondo T, Ichikawa H, Yoshida A, Kobayashi E, Kawai A, Ozaki T, Ochiya T. Fujiwara T, et al. Stem Cells. 2014 Apr;32(4):959-73. doi: 10.1002/stem.1618. Stem Cells. 2014. PMID: 24715690 Clinical Trial.

4

MicroRNAs in soft tissue sarcomas: overview of the accumulating evidence and importance as novel biomarkers.

Fujiwara T, Kunisada T, Takeda K, Uotani K, Yoshida A, Ochiya T, Ozaki T. Fujiwara T, et al. Biomed Res Int. 2014;2014:592868. doi: 10.1155/2014/592868. Epub 2014 Aug 4. Biomed Res Int. 2014. PMID: 25165708 Free PMC article. Review.

5

RPN2 Gene Confers Osteosarcoma Cell Malignant Phenotypes and Determines Clinical Prognosis.

Fujiwara T, Takahashi RU, Kosaka N, Nezu Y, Kawai A, Ozaki T, Ochiya T. Fujiwara T, et al. Mol Ther Nucleic Acids. 2014 Sep 2;3(9):e189. doi: 10.1038/mtna.2014.35. Mol Ther Nucleic Acids. 2014. PMID: 25181275 Free PMC article.

6

Diagnostic value of Thallium-201 scintigraphy in differentiating malignant bone tumors from benign bone lesions.

Inai R, Shinya T, Tada A, Sato S, Fujiwara T, Takeda K, Kunisada T, Yanai H, Ozaki T, Kanazawa S. Inai R, et al. Among authors: fujiwara t. Ann Nucl Med. 2015 Oct;29(8):674-81. doi: 10.1007/s12149-015-0990-6. Epub 2015 Jun 3. Ann Nucl Med. 2015. PMID: 26036991

7

Immunotherapy for Bone and Soft Tissue Sarcomas.

Uehara T, Fujiwara T, Takeda K, Kunisada T, Ozaki T, Udono H. Uehara T, et al. Among authors: fujiwara t. Biomed Res Int. 2015;2015:820813. doi: 10.1155/2015/820813. Epub 2015 Jun 17. Biomed Res Int. 2015. PMID: 26167500 Free PMC article. Review.

8

Second primary osteosarcomas in patients with retinoblastoma.

Fujiwara T, Fujiwara M, Numoto K, Ogura K, Yoshida A, Yonemoto T, Suzuki S, Kawai A. Fujiwara T, et al. Among authors: fujiwara m. Jpn J Clin Oncol. 2015 Dec;45(12):1139-45. doi: 10.1093/jjco/hyv140. Epub 2015 Oct 4. Jpn J Clin Oncol. 2015. PMID: 26438540

9

microRNAs and Soft Tissue Sarcomas.

Fujiwara T, Kunisada T, Takeda K, Ozaki T. Fujiwara T, et al. Adv Exp Med Biol. 2015;889:179-99. doi: 10.1007/978-3-319-23730-5_10. Adv Exp Med Biol. 2015. PMID: 26659002 Review.

10

Ablation of MCL1 expression by virally induced microRNA-29 reverses chemoresistance in human osteosarcomas.

Osaki S, Tazawa H, Hasei J, Yamakawa Y, Omori T, Sugiu K, Komatsubara T, Fujiwara T, Sasaki T, Kunisada T, Yoshida A, Urata Y, Kagawa S, Ozaki T, Fujiwara T. Osaki S, et al. Among authors: fujiwara t. Sci Rep. 2016 Jun 30;6:28953. doi: 10.1038/srep28953. Sci Rep. 2016. PMID: 27356624 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,905 results

Search Page